Výsledky vyhledávání - "Elia Apodaca-Chavez"

Akademický článek

PB2627: THROMBOTIC THROMBOCYTOPENIC PURPURA, RELAPSE RELATED RISK FACTORS IN A CARE CENTER WITH LIMITED ACCESS TO ADAMTS13 LEVELS.

Autor: Santiago Riviello Goya, Sergio Rodriguez-Rodriguez, Mario Meza-Meza, Juan Luis Ontiveros-Austria, Elena Tuna-Aguilar, Roberta Demichelis-Gomez, Sergio I Inclan-Alarcon, Elia Apodaca-Chavez

Publikováno v: HemaSphere, Vol 7, p e19287e8 (2023)

Externí odkaz: https://doaj.org/article/6acd56ea45664ab6bccf602ad66eed47

Zobrazit plný text záznamu

Hematopoietic Cell Transplantation in First Remission in AML in Mexico: Very Low Rates Derived from Early Relapses and Lack of Access

Publikováno v: Blood. 140:10830-10832

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ba9e211334f7cef55d68731276c95925
https://doi.org/10.1182/blood-2022-170200

Zobrazit plný text záznamu

Akademický článek

Are delays in diagnosis and treatment of acute leukemia in a middle-income country associated with poor outcomes? A retrospective cohort study

Autor: Yadith Karina Lopez-Garcia, Mayra Valdez-Carrizales, Jorge Adrián Nuñez-Zuno, Elia Apodaca-Chávez, Juan Rangel-Patiño, Roberta Demichelis-Gómez

Publikováno v: Hematology, Transfusion and Cell Therapy, Vol 46, Iss 4, Pp 366-373 (2024)

Introduction: Acute leukemias (ALs) are aggressive diseases that lead to death without medical attention. We evaluated the association between delays in diagnosis and poor outcomes in AL by evaluating the symptom onset to treatment intervals in adult

Externí odkaz: https://doaj.org/article/ac2b1e36ee764f81b0bce68d8334e67b

Zobrazit plný text záznamu

Myelodysplastic Syndromes in Latin-America - Results from a Novel International Registry: Re-Glam

Autor: Sofia Grille, Elvira DRP Velloso, Matilde Boada, Elia Apodaca Chavez, Andres Gomez-De Leon, Anna Cecilia Rodríguez-Zuñiga, Emmanuel Martínez Moreno, Fernando Perez-Jacobo, Graciela Alfonso, Juan Carlos Serrano, Natalia Tejeira, Lilián Díaz, Valentina Olivares, Laura Kornblihtt, Sergio Schusterschitz, Marcelo Iastrebner

Publikováno v: Blood. 140:4096-4097

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6b99c34fe3e5c52fde48c89c7612c2d2
https://doi.org/10.1182/blood-2022-168893

Zobrazit plný text záznamu

Total Oral Anticoagulation for Classic PNH As Primary Prophylaxis Strategy in a Complement Inhibitor Restricted Scenario: A Retrospective Analysis

Autor: Elia Apodaca Chavez, Aurea Garcés-Martínez, Roberta Demichelis, Juan Rangel-Patiño, Elena Tuna-Aguilar

Publikováno v: Blood. 138:1118-1118

Introduction. Paroxysmal nocturnal hemoglobinuria (PNH) is associated with thrombosis and bone marrow failure. Thrombosis is the leading cause of death and morbidity, with 29-44% of patients presenting at least one thrombotic episode during their dis

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::79c8cc52f12fa3e98ea8362f3a3384a5
https://doi.org/10.1182/blood-2021-153515

Zobrazit plný text záznamu

Akademický článek

Treating Acute Leukemia During the COVID-19 Pandemic in an Environment With Limited Resources: A Multicenter Experience in Four Latin American Countries

Publikováno v: JCO Global Oncology, Vol , Iss 7, Pp 577-584 (2021)

PURPOSEThe COVID-19 pandemic is a colossal challenge for global health; nonetheless, specific subgroups face considerably higher risks for infection and mortality. Among patients with malignant diseases, those with hematologic neoplasms are at a high

Externí odkaz: https://doaj.org/article/c7ef9b5d51e0422197df7a57823d833d

Zobrazit plný text záznamu

Akademický článek

Circulating HMGB1 is increased in myelodysplastic syndrome but not in other bone marrow failure syndromes: proof-of-concept cross-sectional study

Autor: Elia Apodaca-Chávez, Roberta Demichelis-Gómez, Adriana Rosas-López, Nancy R. Mejía-Domínguez, Isabela Galvan-López, Meghan Addorosio, Kevin J. Tracey, Sergio Iván Valdés-Ferrer

Publikováno v: Therapeutic Advances in Hematology, Vol 13 (2022)

Background: Myelodysplastic syndrome (MDS) is associated with persistent immune activation. High mobility group box-1 (HMGB1) is a ubiquitous, functionally diverse, non-histone intranuclear protein. During acute and chronic inflammatory states, HMGB1

Externí odkaz: https://doaj.org/article/02581943d2304d10be8ca6bc903db73c

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání